• About Us
  • Technology
  • News
  • Team
  • Contact
Advamedica
Contact us: +91 88607 86067
Advamedica
  • About Us
  • Technology
  • News
  • Team
  • Contact
TrueScale Capitals leads Series B2 funding for Advamedica

TrueScale Capitals leads Series B2 funding for Advamedica

  • Posted on July 27, 2021
Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale
Continue Reading
Advamedica Receives FDA Clearance for Axiostat Hemostatic Patch

Advamedica Receives FDA Clearance for Axiostat Hemostatic Patch

  • Posted on July 1, 2021
A biomaterial-focused MedTech startup has announced FDA 510(k) clearance of its hemostatic product...
Continue Reading
Advamedica selected to pitch for Medtech Innovator US Military Pitch

Advamedica selected to pitch for Medtech Innovator US Military Pitch

  • Posted on February 20, 2020
Advamedica has been selected for MedTech Innovator US Military Pitch (May 2020) to pitch its Military...
Continue Reading
Omidyar Network leads Series B1 funding for Advamedica

Omidyar Network leads Series B1 funding for Advamedica

  • Posted on January 9, 2020
Advamedica has raised $5.2 Mn in Series B1 round of funding led by Omidyar Network, along with participation...
Continue Reading
Advamedica announces world-class scientific advisory board

Advamedica announces world-class scientific advisory board

  • Posted on March 14, 2019
Advamedica has announced its top-notch scientific advisory board and research collaboration...
Continue Reading
Axiostat receives US FDA clearance

Axiostat receives US FDA clearance

  • Posted on February 28, 2018
US FDA granted 510(k) clearance to Axiostat Chitosan Hemostatic Dressing, which is cleared...
Continue Reading
University of California Series B round of funding for Advamedica

University of California Series B round of funding for Advamedica

  • Posted on January 26, 2018
Advamedica has raised $7.4 million Series B funding led by UC-RNT fund -- set up by the University...
Continue Reading

Advamedica Inc.
Harvard Square,
1 Mifflin Place, Suite 400,
Cambridge, Massachusetts
02138 USA

office@advamedica.com

About

Technology 

News

Team 

Contact

Follow us on social media

Linkedin Twitter
Advamedica Inc. 2015-2022, All Rights Reserved ©

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”

Cancel
Continue

Contact us

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”

Cancel
Continue